Index -
P/E 29.27
EPS (ttm) 3.09
Insider Own 17.27%
Shs Outstand 112.18M
Perf Week 0.02%
Market Cap 12.19B
Forward P/E 22.03
EPS next Y 4.11
Insider Trans -0.45%
Shs Float 111.36M
Perf Month 4.45%
Enterprise Value 11.92B
PEG 1.73
EPS next Q 1.11
Inst Own 88.22%
Short Float 3.83%
Perf Quarter 55.90%
Income 423.78M
P/S 4.40
EPS this Y 22.07%
Inst Trans 3.41%
Short Ratio 2.39
Perf Half Y 59.97%
Sales 2.77B
P/B 2.77
EPS next Y 7.26%
ROA 8.32%
Short Interest 4.26M
Perf YTD 3.72%
Book/sh 32.68
P/C 31.21
EPS next 5Y 12.76%
ROE 10.01%
52W High 101.40 -10.69%
Perf Year 3.88%
Cash/sh 2.90
P/FCF 21.03
EPS past 3/5Y -19.65% -13.26%
ROIC 9.41%
52W Low 51.79 74.86%
Perf 3Y 25.24%
Dividend Est. -
EV/EBITDA 16.44
Sales past 3/5Y 38.03% 26.25%
Gross Margin 61.05%
Volatility 5.01% 2.85%
Perf 5Y 36.12%
Dividend TTM -
EV/Sales 4.30
EPS Y/Y TTM 364.73%
Oper. Margin 16.20%
ATR (14) 2.97
Perf 10Y 228.24%
Dividend Ex-Date -
Quick Ratio 2.47
Sales Y/Y TTM 11.75%
Profit Margin 15.30%
RSI (14) 55.07
Recom 2.00
Dividend Gr. 3/5Y - -
Current Ratio 4.13
EPS Q/Q 134.07%
SMA20 1.39%
Beta 1.06
Target Price 106.27
Payout 0.00%
Debt/Eq 0.03
Sales Q/Q 22.91%
SMA50 5.43%
Rel Volume 0.38
Prev Close 90.16
Employees 5300
LT Debt/Eq 0.02
Earnings Nov 06 AMC
SMA200 34.71%
Avg Volume 1.78M
Price 90.56
IPO Aug 03, 2012
Option/Short Yes / Yes
EPS/Sales Surpr. 51.13% 4.68%
Trades
Volume 221,103
Change 0.45%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-07-25 Upgrade
Truist
Hold → Buy
$93
Nov-07-25 Upgrade
BofA Securities
Neutral → Buy
$91
Oct-28-25 Resumed
Stifel
Hold
$64
May-27-25 Downgrade
BTIG Research
Buy → Neutral
Jan-10-25 Upgrade
BofA Securities
Underperform → Neutral
$97
Dec-02-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$83 → $100
Aug-07-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$60 → $78
May-20-24 Upgrade
Piper Sandler
Neutral → Overweight
$60 → $80
Mar-18-24 Upgrade
BTIG Research
Neutral → Buy
$60
Oct-20-23 Initiated
ROTH MKM
Buy
$75
Sep-19-23 Upgrade
Stifel
Hold → Buy
$61
Mar-30-23 Upgrade
Canaccord Genuity
Hold → Buy
$67
Feb-13-23 Downgrade
BofA Securities
Buy → Underperform
$83 → $63
Feb-10-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$67
Feb-10-23 Downgrade
Truist
Buy → Hold
$85 → $70
Feb-10-23 Downgrade
Needham
Buy → Hold
Feb-10-23 Downgrade
Loop Capital
Buy → Hold
$90 → $70
Feb-10-23 Downgrade
BTIG Research
Buy → Neutral
Oct-18-22 Initiated
Barclays
Overweight
$69
Oct-12-22 Initiated
Jefferies
Buy
$75
Show Previous Ratings
Jan-12-26 11:32PM
Jan-11-26 11:37PM
Jan-09-26 09:45AM
Jan-08-26 04:39PM
11:43AM
11:23AM
Loading…
11:23AM
09:50AM
06:31AM
05:12AM
Jan-07-26 07:11PM
04:27PM
Jan-03-26 08:00AM
(Investor's Business Daily)
Dec-31-25 07:32AM
Dec-23-25 09:45AM
Dec-22-25 03:00PM
09:40AM
Loading…
Dec-19-25 09:40AM
Dec-18-25 11:12PM
(Investor's Business Daily)
03:11PM
09:08AM
Dec-16-25 02:39PM
(Investor's Business Daily)
Dec-08-25 10:33PM
Dec-04-25 11:43AM
09:45AM
08:27AM
Dec-03-25 12:45PM
12:43PM
11:40AM
09:40AM
08:14AM
08:08AM
09:50AM
Loading…
Dec-02-25 09:50AM
08:25AM
07:53AM
Dec-01-25 05:12PM
(Investor's Business Daily)
09:04AM
07:52AM
Nov-26-25 03:27AM
Nov-25-25 02:42PM
(Investor's Business Daily)
08:24AM
(Investor's Business Daily)
07:03AM
Nov-24-25 05:15PM
(Investor's Business Daily)
01:47PM
(Investor's Business Daily)
11:35AM
(Investor's Business Daily)
09:55AM
Nov-20-25 05:46PM
09:16AM
Nov-19-25 01:45PM
(Investor's Business Daily)
Nov-18-25 01:56PM
Nov-17-25 09:33AM
Nov-14-25 12:45PM
10:19AM
(Investor's Business Daily)
09:50AM
08:21AM
Nov-13-25 08:52AM
12:35AM
Nov-11-25 09:45AM
Nov-10-25 11:41PM
Nov-09-25 12:40PM
Nov-07-25 04:21PM
04:14PM
(Investor's Business Daily)
02:17PM
01:11PM
11:08AM
11:04AM
09:26AM
06:36AM
Nov-06-25 07:30PM
06:55PM
05:55PM
(Associated Press Finance)
05:08PM
04:15PM
Nov-05-25 07:10PM
11:54AM
09:15AM
Nov-04-25 10:12PM
06:20PM
08:39AM
08:39AM
08:38AM
Oct-31-25 10:15AM
Oct-30-25 10:00AM
Oct-29-25 09:40AM
Oct-28-25 05:15PM
09:16AM
Oct-24-25 09:00AM
Oct-23-25 07:53AM
Oct-17-25 09:08AM
Oct-16-25 04:30PM
Oct-14-25 04:40PM
11:40AM
08:34AM
Oct-06-25 11:33PM
Oct-02-25 10:13AM
Oct-01-25 12:01AM
Sep-29-25 09:40AM
Sep-12-25 09:40AM
Sep-04-25 12:14PM
Sep-02-25 01:05AM
Aug-28-25 04:30PM
Aug-27-25 09:40AM
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kline Kyle Senior Vice President, CFO Jan 08 '26 Option Exercise 51.87 3,594 186,421 3,594 Jan 12 05:40 PM Kline Kyle Senior Vice President, CFO Jan 08 '26 Sale 101.10 3,594 363,353 0 Jan 12 05:40 PM Norwalk Leslie V Director Jan 08 '26 Sale 101.10 2,000 202,200 10,419 Jan 12 05:36 PM Kline Kyle Officer Jan 08 '26 Proposed Sale 101.05 3,594 363,167 Jan 08 01:52 PM Norwalk Leslie V Director Jan 08 '26 Proposed Sale 101.00 2,000 202,000 Jan 08 01:10 PM Norwalk Leslie V Director Dec 12 '25 Sale 88.85 4,000 355,400 12,419 Dec 16 04:18 PM Norwalk Leslie V Director Dec 12 '25 Proposed Sale 88.75 4,000 355,000 Dec 12 04:00 PM Paul David C Executive Chairman Dec 08 '25 Option Exercise 25.52 34,375 877,250 60,417 Dec 10 04:37 PM Kline Kyle Senior Vice President, CFO Dec 01 '25 Option Exercise 59.86 18,542 1,109,876 18,542 Dec 03 08:23 PM Kline Kyle Senior Vice President, CFO Dec 01 '25 Sale 90.00 18,542 1,668,780 0 Dec 03 08:23 PM Kline Kyle Officer Dec 01 '25 Proposed Sale 89.95 18,542 1,667,847 Dec 01 03:59 PM Huller Kelly SVP, GC, Corporate Secretary Nov 25 '25 Option Exercise 25.96 7,500 194,700 7,500 Nov 28 05:31 PM Huller Kelly SVP, GC, Corporate Secretary Nov 25 '25 Sale 90.00 7,500 675,000 0 Nov 28 05:31 PM Huller Kelly Officer Nov 25 '25 Proposed Sale 90.00 7,500 675,000 Nov 25 11:07 AM Davidar David D Director Nov 12 '25 Option Exercise 25.52 25,000 638,000 541,275 Nov 13 05:12 PM Davidar David D Director Nov 12 '25 Sale 86.00 25,000 2,150,005 516,275 Nov 13 05:12 PM ZARRILLI STEPHEN T Director Nov 11 '25 Option Exercise 44.14 25,000 1,103,500 25,000 Nov 13 05:06 PM ZARRILLI STEPHEN T Director Nov 11 '25 Sale 84.29 25,000 2,107,258 0 Nov 13 05:06 PM Davidar David D Director Nov 12 '25 Proposed Sale 85.95 25,000 2,148,750 Nov 12 12:35 PM ZARRILLI STEPHEN T Director Nov 11 '25 Proposed Sale 84.24 25,000 2,106,000 Nov 12 08:45 AM RHOADS ANN D Director Nov 10 '25 Proposed Sale 85.00 2,000 170,000 Nov 10 04:55 PM RHOADS ANN D Director Nov 07 '25 Sale 81.00 8,000 648,000 17,384 Nov 10 04:15 PM RHOADS ANN D Director Nov 10 '25 Sale 85.00 2,000 170,000 15,384 Nov 10 04:15 PM RHOADS ANN D Director Nov 07 '25 Proposed Sale 80.96 8,000 647,681 Nov 07 12:17 PM RHOADS ANN D Director Sep 15 '25 Sale 58.46 10,000 584,600 25,384 Sep 16 05:16 PM RHOADS ANN D Director Sep 15 '25 Proposed Sale 58.40 10,000 584,000 Sep 15 03:51 PM RHOADS ANN D Director Feb 28 '25 Sale 78.68 7,500 590,100 35,384 Mar 04 04:38 PM RHOADS ANN D Director Feb 28 '25 Proposed Sale 78.67 7,500 590,000 Feb 28 11:05 AM